Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study

NCT00124865 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped Sponsor

Conditions

Diarrhea

Interventions

BIOLOGICAL: rFla-MBP

Sponsor

U.S. Army Medical Research and Development Command